Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
153.10
+1.58 (1.04%)
Dec 20, 2024, 4:00 PM EST - Market closed
Quest Diagnostics Revenue
Quest Diagnostics had revenue of $2.49B in the quarter ending September 30, 2024, with 8.41% growth. This brings the company's revenue in the last twelve months to $9.54B, up 2.60% year-over-year. In the year 2023, Quest Diagnostics had annual revenue of $9.25B, down -6.38%.
Revenue (ttm)
$9.54B
Revenue Growth
+2.60%
P/S Ratio
1.79
Revenue / Employee
$198,729
Employees
48,000
Market Cap
17.09B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 9.25B | -631.00M | -6.38% |
| Dec 31, 2022 | 9.88B | -905.00M | -8.39% |
| Dec 31, 2021 | 10.79B | 1.35B | 14.32% |
| Dec 31, 2020 | 9.44B | 1.71B | 22.15% |
| Dec 31, 2019 | 7.73B | 195.00M | 2.59% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Molina Healthcare | 37.54B |
| Labcorp Holdings | 12.71B |
| ICON Public Limited Company | 8.31B |
| STERIS | 5.33B |
| Hologic | 4.03B |
| Align Technology | 3.96B |
| The Cooper Companies | 3.90B |
| BeiGene | 3.35B |
DGX News
- 18 days ago - Quest Diagnostics to Speak at the 7th Annual Evercore HealthCONx Conference - PRNewsWire
- 18 days ago - Quest Diagnostics Launches Health Coaching on questhealth.com to Help Individuals Take Control of Their Health - PRNewsWire
- 26 days ago - 15 stocks — including Palantir and Nvidia — whose sales estimates have risen the most this earnings season - Market Watch
- 5 weeks ago - Augurex Life Sciences and Quest Diagnostics Collaborate to Improve Rheumatoid Arthritis Diagnosis and Management - Business Wire
- 5 weeks ago - Quest Diagnostics Declares Quarterly Cash Dividend - PRNewsWire
- 2 months ago - Quest Diagnostics Has Massive Secular Tailwinds And A Strong Base - Seeking Alpha
- 2 months ago - Quest Diagnostics: Organic Growth Leads To Q3 Earnings Beat - Seeking Alpha
- 2 months ago - US lab operator Quest Diagnostics to launch bird flu test at end of October - Reuters